South Bend, Ind.-based Beacon Health System has wrapped a 15,000-square-foot, two-story expansion at Beacon Granger (Ind.) Hospital to grow its outpatient services footprint. The $11.9 million ...
Despite living with canine cognitive dysfunction syndrome (similar to dementia in humans), the 16-year-old dog suddenly made a "U-turn"—remembering he needed his nighttime snack, as the text overlay ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
The condition known as SSNHL, affects one ear at a time. Its onset can occur either during a single night, or it may develop ...
US FDA approves Vanda Pharma’s Nereus, an oral NK-1 receptor antagonist for prevention of vomiting induced by motion: Washington Friday, January 2, 2026, 15:00 Hrs [IST] Vanda P ...
The FDA has approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for preventing motion-induced vomiting in adults ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Explore the science behind immersive addiction therapy programs, how evidence-based approaches improve treatment outcomes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback